Supplements That Can Cause Digoxin Toxicity
While the provided guidelines focus on prescription drug interactions rather than supplements, several herbal products can cause digoxin toxicity through two distinct mechanisms: direct interference with digoxin immunoassays (falsely elevated levels) and true pharmacokinetic interactions that alter digoxin clearance.
Supplements That Directly Interfere with Digoxin Assays
The following herbal supplements contain cardiac glycosides or digoxin-like compounds that cross-react with digoxin immunoassays, potentially causing false-positive or falsely elevated digoxin levels 1:
- Chan Su (Chinese toad venom)
- Lu-Shen-Wan (traditional Chinese medicine)
- Dan Shen (Salvia miltiorrhiza)
- Asian and Siberian ginseng
- Oleander-containing supplements (including yellow oleander/Thevetia peruviana)
- Ashwagandha
Critical Clinical Pitfall: Yellow Oleander Contamination
A particularly dangerous scenario involves mislabeled or adulterated weight-loss supplements. A recent case documented severe digoxin-like toxicity from a supplement labeled as "Tejocote root" (Crataegus mexicana) that actually contained yellow oleander (Thevetia peruviana) 2. The patient presented with classic digoxin toxicity symptoms—nausea, vomiting, hypotension, bradycardia, first-degree AV block, and characteristic ST-segment changes—despite never taking digoxin. This underscores that imported or online-purchased supplements pose significant risk for containing undisclosed cardiac glycosides.
Supplements That Alter Digoxin Pharmacokinetics
St. John's Wort (Hypericum perforatum)
St. John's wort significantly reduces digoxin levels by inducing P-glycoprotein efflux pumps and cytochrome P-450 enzymes, increasing digoxin clearance 1. This interaction causes subtherapeutic digoxin concentrations and potential treatment failure rather than toxicity. However, if St. John's wort is discontinued in a patient whose digoxin dose was increased to compensate, rebound toxicity can occur.
Sennosides (Senna)
Sennosides, commonly used laxatives, increase the risk of digoxin toxicity by 1.61-fold, with higher risk (1.93-fold) at doses ≥24 mg daily 3. This population-based study of 222,527 heart failure patients found that sennoside use within 14 days preceding hospitalization was independently associated with digoxin toxicity. The mechanism likely involves electrolyte disturbances (particularly hypokalemia from diarrhea) that potentiate digoxin's cardiac effects.
Electrolyte-Related Supplement Risks
While not supplements per se, the FDA label emphasizes that calcium supplements, particularly when administered intravenously, can produce serious arrhythmias in digitalized patients 4. The ACC/AHA guidelines similarly note that hypokalemia and hypomagnesemia increase digoxin toxicity risk even at therapeutic digoxin levels 5. Therefore, any supplement causing electrolyte depletion (potassium-depleting diuretics, excessive laxative use) indirectly increases toxicity risk.
Clinical Approach to Supplement-Related Digoxin Toxicity
Key Diagnostic Considerations:
Obtain detailed supplement history, specifically asking about:
- Weight-loss products (high contamination risk)
- Traditional Chinese/Asian medicines
- Herbal cardiac or energy supplements
- Online or imported products
- Recent laxative use
Recognize that digoxin assay results may be misleading when herbal cardiac glycosides are present—the patient may have "digoxin toxicity" with undetectable true digoxin levels or falsely elevated levels 2, 6
Monitor electrolytes closely (potassium, magnesium, calcium) as these critically modulate digoxin toxicity independent of serum digoxin concentration 5
Consider toxicity based on clinical presentation rather than relying solely on serum digoxin levels, as toxicity can occur at therapeutic concentrations when predisposing factors exist 7, 8
Management Priorities:
- Discontinue all supplements immediately when digoxin toxicity is suspected
- Correct electrolyte abnormalities (hypokalemia, hypomagnesemia) as these potentiate toxicity 5
- Consider digoxin-specific antibody fragments for life-threatening presentations regardless of measured digoxin level 8
- Recognize that standard toxicology screens do not detect plant-derived cardiac glycosides; specialized testing (LC-HRMS, DNA barcoding) may be needed for definitive identification 2
The most important clinical pearl: maintain high suspicion for exotic plant poisoning in any patient with cardiac glycoside-like symptoms (bradycardia, AV block, characteristic ST changes, GI symptoms) who uses supplements, even if they deny digoxin use or have negative/low digoxin levels.